Super Religare Labs

• *Super Religare Labs IPO likely in 2011, says head Malvinder

  MUMBAI, SEPTEMBER 01Phone: +91 (22) 6147 5100. feedback@tickerplantindia.com Copyright (c) TickerPlant Ltd.Copyright (c) TickerPlant Ltd.

• Fortis to buy 86% stake in Super Religare Labs for Rs 930 crore

  Fortis Healthcare (India) today said its board has approved acquisition of 86 per cent stake in Super Religare Laboratories (SRL) to be based on third-party valuation by private equity fund Avigo Capital Partners, under which it is likely to pay around Rs 930 crore. "The Board of Fortis Healthcare (India) Ltd in its meeting today approved to...

• Avigo Capital picks up 9.27% stake in Super Religare Labs

  Private equity fund Avigo Capital Partners has picked up a 9.27 per cent stake in a pre-IPO placement in Super Religare Laboratories (SRL) for an aggregate amount of around Rs 100 crore, Avigo said. Avigo has signed a share subscription agreement with SRL under which it will subscribe to 9.27 per cent of the post investment equity share cap...

• Fortis Healthcare to buy 86% in Super Religare Labs

  Fortis Healthcare on Thursday said  its board has accorded in-principal approval to acquire 86 per cent stake in Super Religare Laboratories (SRL) from promoters for an undisclosed amount. Both Fortis Healthcare and SRL are promoted by billionaire brothers Malvinder Mohan Singh and Shivinder Mohan Singh. The in-principal approval ...